Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mismetti

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Haematologica|March 26, 2003
The location of deep-vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosisSilvy Laporte, Bernard Tardy, Sara Quenet, et al.
Thrombosis Research|October 20, 2012
TFPI resistance related to inherited or acquired protein S deficiencyBrigitte Tardy-Poncet, Michèle Piot, Dominique Brunet, et al.
Journal of Cellular Physiology|January 27, 2019
Effects of heparin and derivatives on podocytes: An in vitro functional and morphological evaluationOlivier Delézay, Zhiguo Hé, Odile Sabido, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 17, 2020
Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expressionPierre-Benoît Bonnefoy, Elodie Jacqueroux, Xavier Delavenne, et al.
Thrombosis and Haemostasis|April 6, 2012
Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort studyPatrick Mismetti, Charles-Marc Samama, Nadia Rosencher, et al.
European Journal of Clinical Pharmacology|March 27, 2012
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgeryXavier Delavenne, Paul Zufferey, Philippe Nguyen, et al.
Thrombosis and Haemostasis|February 13, 2004
Long term prognosis of patients with myocardial infarction and normal coronary angiography: impact of inherited coagulation disordersAntoine Da Costa, Brigitte Tardy, Kamel Haouchette, et al.
Anesthesiology|October 27, 2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?Paul Zufferey, Fanette Merquiol, Silvy Laporte, et al.
Therapie|August 2, 2012
[Severe meprobamate poisoning: description of 146 cases in a French department]Bérenger Mounier, Bertrand Pons, Xavier Delavenne, et al.
Scientific Reports|September 23, 2020
Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancerJane-Chloé Trone, Edouard Ollier, Céline Chapelle, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Haematologica|March 26, 2003
The location of deep-vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosisSilvy Laporte, Bernard Tardy, Sara Quenet, et al.
Thrombosis Research|October 20, 2012
TFPI resistance related to inherited or acquired protein S deficiencyBrigitte Tardy-Poncet, Michèle Piot, Dominique Brunet, et al.
Journal of Cellular Physiology|January 27, 2019
Effects of heparin and derivatives on podocytes: An in vitro functional and morphological evaluationOlivier Delézay, Zhiguo Hé, Odile Sabido, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 17, 2020
Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expressionPierre-Benoît Bonnefoy, Elodie Jacqueroux, Xavier Delavenne, et al.
Thrombosis and Haemostasis|April 6, 2012
Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort studyPatrick Mismetti, Charles-Marc Samama, Nadia Rosencher, et al.
European Journal of Clinical Pharmacology|March 27, 2012
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgeryXavier Delavenne, Paul Zufferey, Philippe Nguyen, et al.
Thrombosis and Haemostasis|February 13, 2004
Long term prognosis of patients with myocardial infarction and normal coronary angiography: impact of inherited coagulation disordersAntoine Da Costa, Brigitte Tardy, Kamel Haouchette, et al.
Anesthesiology|October 27, 2006
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?Paul Zufferey, Fanette Merquiol, Silvy Laporte, et al.
Therapie|August 2, 2012
[Severe meprobamate poisoning: description of 146 cases in a French department]Bérenger Mounier, Bertrand Pons, Xavier Delavenne, et al.
Scientific Reports|September 23, 2020
Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancerJane-Chloé Trone, Edouard Ollier, Céline Chapelle, et al.
Pageof 18